Detalles de la búsqueda
1.
BRCA1/2 reversion mutations in a pan-cancer cohort.
Cancer Sci
; 115(2): 635-647, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041241
2.
Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer.
Jpn J Clin Oncol
; 54(5): 569-576, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305663
3.
Cancer history and physical function in patients with cardiovascular disease.
Heart Vessels
; 39(7): 654-663, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578318
4.
Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma.
Invest New Drugs
; 41(1): 115-121, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36633784
5.
The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer.
Oncology
; 101(11): 695-704, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494886
6.
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.
Oncology
; 101(1): 69-76, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103811
7.
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Oncology
; 101(11): 685-694, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37166346
8.
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.
Invest New Drugs
; 40(1): 182-189, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415485
9.
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
Invest New Drugs
; 40(2): 430-437, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807331
10.
Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040).
BMC Cancer
; 22(1): 1314, 2022 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36522630
11.
[Clinical Outcome of Microsatellite Instability-High Patients Treated with Pembrolizumab and Genetic Counseling].
Gan To Kagaku Ryoho
; 49(10): 1099-1104, 2022 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-36281602
12.
Phase II study of amrubicin plus erlotinib in previously treated, advanced non-small cell lung cancer with wild-type epidermal growth factor receptor (TORG1320).
Invest New Drugs
; 39(2): 530-536, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159674
13.
Factors Related to Oncologists' Use of the Disease Treatment and Employment Support Guidance Fee.
J UOEH
; 43(4): 427-432, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897172
14.
Promoter DNA Hypermethylation of the Cysteine Dioxygenase 1 (CDO1) Gene in Intraductal Papillary Mucinous Neoplasm (IPMN).
Ann Surg Oncol
; 27(10): 4007-4016, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32144623
15.
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
Invest New Drugs
; 38(6): 1906-1914, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415486
16.
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Invest New Drugs
; 38(3): 885-893, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32157598
17.
Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancer.
Jpn J Clin Oncol
; 50(3): 318-324, 2020 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31804689
18.
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.
Invest New Drugs
; 36(1): 45-52, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28466376
19.
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Oncology
; 94(4): 207-214, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393275
20.
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Oncology
; 95(2): 109-115, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29698957